420 Investor Interview: Paul Rosen, CEO of PharmaCan Capital

One of the most exciting themes for those looking to capitalize on the changing global cannabis industry is the rollout of Canada's Marihuana for Medical Purposes Regulations (MMPR). Health Canada, which oversees Canada’s national medical marijuana program, has issued licenses to 23 companies, several of which trade or are soon expected to trade publicly. PharmaCan Capital Corp., which is based in Toronto, has made investments in 5 of Canada’s current Licensed Producers. The company, which just went public on the TSX Venture Exchange under the symbol MJN, is led by Paul Rosen, its President and CEO.


Alan: Thank you, Paul, for taking the time to tell us about PharmaCan Capital and congratulations on your recent listing. Before we discuss your company, can you tell us about your background?

Paul: I was born and raised in Toronto, where I reside with my family. I earned a degree in economics, followed by a law degree from the University of Toronto. I practiced criminal and constitutional law in Canada for a number of years, and I remain a member of the Law Society of Upper Canada. I have also played a leadership role in the development number of companies and became the President and CEO of PharmaCan in March 2013.

Alan: Why did you decide to enter the MMJ industry?

Paul: I entered the medical marijuana industry as it provides a unique combination of opportunity, entrepreneurial spirit and the ability to deliver a plant with incredible therapeutic properties. While I have had previous success starting and building companies, PharmaCan provided the extra opportunity to be a stakeholder in the development of an important new industry that will improve the quality of life for so many Canadians. I could not be more passionate, excited and committed.

Alan: Can you describe the efforts ...

Read More
Comments

Election Survey 11/03/14 - Public Survey

420 Investor conducted a survey for the public that was exactly the same as its internal survey.  The public survey, which was posted on Twitter and Facebook, consisted of six questions and was open for 50 hours, closing at 9 A.M ...

Read More
Comments

Stay Informed with the 420 Investor Newsletter

After a year of helping investors navigate the "Wild West" of the cannabis stock sector as 420 Investor has evolved into the leading collaborative due diligence platform, we are pleased to offer the 420 Investor Newsletter.

This monthly effort is ...

Read More
Comments

GrowBLOX "Blows" It

GrowBLOX Sciences (GBLX) posted a press release this morning. This company has spent an enormous amount of money on p.r. and investor relations and has pushed the envelope (using GoogleAds, for instance, to promote its ticker). Shockingly, the company ...

Read More
Comments

420 Investor Interview: Tom Bollich, CEO of Surna

Surna (SRNA), based in Boulder, CO, addresses one of the key challenges facing the cannabis cultivation industry: Energy consumption. The company, which began operations this year, has technology that it has acquired that will help growers reduce one of the ...

Read More
Comments

Guest Post - Desmond Fargo: "Cen Biotech: A Promise Delivered"

The author of this article, Desmond Fargo, gave me permission to publish this piece on Creative Edge Nutrition (FITX)

The purpose of this article is to provide useful insight into Cen Biotech's recent press release regarding license, and also ...

Read More
Comments

Basics By Brochstein - Volume 1

This is series of nine short videos designed to help with novice education. Each video was about 8-12 minutes, with the intention of explaining key concepts in plain English, all with the goal of making you a more informed investor ...

Read More
Comments

Interview with Paul Enright, CEO of United Cannabis (CNAB)

United Cannabis (CNAB) is a recent reverse-merger, formerly known as MySkin. The company has a relationship with Colorado-based dispensary RiverRock that will allow it to expand the brand and the intellectual property. The most recent share-structure was conveyed on April ...

Read More
Comments

Interview with Ebbu CEO Dooma Wendschuh by 420 Investor (Public Version)

I spoke with Dooma Wendschuh last week, and he is a member here at 420 Investor (through our complimentary Corporate Access program). I asked if "ebbu" has any signficance, and it doesn't. The company is taking a very scientific ...

Read More
Comments

A Look At 2014's Leading Cannabis Stocks (Part 1)

Even though cannabis-sector stocks have dropped more than 50 percent since the March peak, the Benzinga 420 Marijuana Index is still up 244 percent YTD.

The burst at the beginning of the year came after widespread media coverage of Colorado's ...

Read More
Comments

The Daily Dab: A Quick Hit On Cannabis Stocks 04/21/14

Typepad, where the Daily Dab is hosted, is down due to a denial of service attack.  I am going to publish this here today...

Denver, CO

www.WeedStockConference.com

Cannabis stocks paused after two days of sharp gains, with 42 ...

Read More
Comments

Who are 420 Investors?

This is the second survey of 420 Investor subscribers.  The results of the first one were based on 222 responses in late January (out of 419 members at the time), and we had 327 this time (out of approximately 1250 ...

Read More
Comments